CMC Analytical Comparability: Methods & Strategies for Biosimilars & Biobetters 2015

Biologics, Biosimilars and Biobetters are considered as the growth engine of the pharmaceutical industry. By 2016, eight of the top-selling 10 drugs will be biologics. Come to discuss the global context of Biologics, Biosimilars & Biobetters at our masterclass.

Key Topics
-Analytical Comparability of Biologics, Biosimilars & Biobetters
-Comparability in Biosimilar Development
-The analytical strategies of protein characterisation of Biosimilars
-New developments in structure function relationship
-The structure of proteins
-In vitro pharmacology
-CASE STUDIES
-SPECIAL FEATURE: Discussion and Q&A Session with all of the trainers